FX-322 is Frequency’s lead product candidate, designed to regenerate auditory sensory hair cells in the cochlea and improve hearing in patients with sensorineural hearing loss (SNHL). A Phase 1/2 ...
Shortly before his death in August 2025, A. James Hudspeth and his team in the Laboratory of Sensory Neuroscience at The ...
The frequency of occurrence of words and sounds has a pervasive influence on typically developing children’s language acquisition. For instance, highly frequent words appear earliest in a child’s ...
Top-Line Results Show Consistent Drug Entry in All Patients WOBURN, Mass.--(BUSINESS WIRE)-- Frequency Therapeutics, Inc. (Nasdaq: FREQ), today announced top-line data from an exploratory clinical ...
Retail investors seem to have spotted an opportunity in the sudden feud between U.S. President Donald Trump and his former ally, Tesla CEO Elon Musk, scooping up shares of the electric car maker as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback